289 related articles for article (PubMed ID: 33174028)
21. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.
Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH
Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330
[TBL] [Abstract][Full Text] [Related]
22. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
[TBL] [Abstract][Full Text] [Related]
23. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
24. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis.
Yao X; Yan C; Zhang L; Li Y; Wan Q
Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
26. Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs.
Saha A; Lee YC; Zhang Z; Chandra G; Su SB; Mukherjee AB
J Biol Chem; 2010 Apr; 285(14):10822-31. PubMed ID: 20118237
[TBL] [Abstract][Full Text] [Related]
27. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.
Ghavami S; Rashedi I; Dattilo BM; Eshraghi M; Chazin WJ; Hashemi M; Wesselborg S; Kerkhoff C; Los M
J Leukoc Biol; 2008 Jun; 83(6):1484-92. PubMed ID: 18339893
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
Grebhardt S; Veltkamp C; Ströbel P; Mayer D
Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
[TBL] [Abstract][Full Text] [Related]
29. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MALAT1 affects high glucose-induced endothelial cell proliferation, apoptosis, migration and angiogenesis by regulating the PI3K/Akt signaling pathway.
Zhang SH; Zhang SG; Zhou P; Wei X; Mao XD; Lin SG; Liu C
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8551-8559. PubMed ID: 31646587
[TBL] [Abstract][Full Text] [Related]
31. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models.
Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS
Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838
[TBL] [Abstract][Full Text] [Related]
32. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4.
Yi J; Gao ZF
Int J Biol Macromol; 2019 Jun; 130():1-9. PubMed ID: 30716366
[TBL] [Abstract][Full Text] [Related]
34. Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat.
Taccioli C; Wan SG; Liu CG; Alder H; Volinia S; Farber JL; Croce CM; Fong LY
Gastroenterology; 2009 Mar; 136(3):953-66. PubMed ID: 19111725
[TBL] [Abstract][Full Text] [Related]
35. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.
Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG
PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809
[TBL] [Abstract][Full Text] [Related]
36. Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway.
Wang Q; Liu J; Guo T; Liu D; Pan J
Med Sci Monit; 2019 Jan; 25():700-710. PubMed ID: 30675875
[TBL] [Abstract][Full Text] [Related]
37. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
[TBL] [Abstract][Full Text] [Related]
38. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.
Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D
Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279
[TBL] [Abstract][Full Text] [Related]
39. Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway.
Wu H; Xiao C; Zhao Y; Yin H; Yu M
J Diabetes Res; 2021; 2021():2936667. PubMed ID: 34447854
[TBL] [Abstract][Full Text] [Related]
40. exMCAM-Fc, an S100A8/A9-mediated-metastasis blocker, efficiently reduced the number of circulating tumor cells that appeared in the blood flow.
Tomonobu N; Kinoshita R; Sakaguchi M
Mol Biol Rep; 2020 Jun; 47(6):4879-4883. PubMed ID: 32383137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
